Latest Breaking News On - பர்‌ட்யூ ஆராய்ச்சி பூங்கா - Page 5 : comparemela.com

Startup seeks partners to advance virus therapeutics Phytoption LLC, a Purdue University-affiliated startup, is advancing the development of antiviral therapeutics in the fight against COVID-19 and other viral diseases. (Image provided) WEST LAFAYETTE, Ind. – A Purdue University-affiliated startup is advancing the development of antiviral therapeutics in the fight against COVID-19 and other viral diseases. Phytoption LLC, in the Purdue Research Park, has been working on the commercialization of Purdue initiated OHPP nanotechnology that significantly boosts drug solubility. A soluble niclosamide drug formulation has been developed using such technology. Niclosamide, a drug used to treat tapeworms, has been found to have a broad-spectrum antiviral effect against many viruses including SARS-CoV-2, the virus that causes the COVID-19 pandemic. But the drug itself has limited potential because its structure makes it difficult to dissolve and for patients to absorb, especially in c

United statesChris adamYuan yaoJoanne zhangMost innovative universityPurdue universityDrug administrationPurdue research parkOffice of technology commercializationPurdue institute of inflammationEarly treatment fundPurdue research foundationUniversity of chicagoPurdue university affiliatedTreatment fundThomas sors